Rankings
▼
Calendar
SLDB Q4 2020 Earnings — Solid Biosciences Inc. Revenue & Financial Results | Market Cap Arena
SLDB
Solid Biosciences Inc.
$581M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$21M
Net Income
-$21M
EPS (Diluted)
$-4.54
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
$1M
Free Cash Flow
$1M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$171M
Total Liabilities
$39M
Stockholders' Equity
$132M
Cash & Equivalents
$155M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$21M
-$32M
+34.0%
Net Income
-$21M
-$32M
+32.9%
← FY 2020
All Quarters
Q1 2021 →